The laboratory industry’s forward thinkers define molecular diagnostics and genetic testing as both the future of pathology and the #1 opportunity to add clinical value while earning appropriate reimbursement.
Personalized medicine and predictive medicine have become a reality. As molecular technology and personalized medicine increasingly becomes the default position for clinical diagnostics laboratories, these modalities place significant demands on laboratory information systems. Although hospitals and healthcare institutions often focus on an electronic medical records system that includes a laboratory information system (LIS), those LIS’s do not typically have the functionality needed to handle current molecular testing needs, or needs expected in the near future.
DarkDaily.com is pleased to offer a recently published White Paper that discusses the trends in increasing use of genetic and molecular testing, the growth of big data in healthcare, and the challenges facing laboratories in handling the complexities of personalized medicine.
“Molecular Information Management Systems (MIMS): Pathologists are Using MIMS to Revolutionize Personalized and Predictive Medicine” discusses why the diagnostic laboratory’s need for a molecular information management system has become increasingly important; specifically one that can handle the complex workflows of various molecular platforms and modalities, and accommodate the large data volume, digital imaging and complex reporting needs that personalized medicine will require. The White Paper also outlines the steps diagnostic labs can take to put into place the appropriate system for them, and realize the potential from having the ability to collect, analyze, and report data from molecular assays and genetic tests.
At DarkDaily.com, readers can access free publications on a variety of topics tailored specifically to the needs of laboratory administrators, lab managers, pathologists, and lab industry consultants.
Related Information:
